Milestone Pharmaceuticals Inc (MIST) - Gunggung dhuwit awis saben saham

Milestone Pharmaceuticals Inc - logo grafis emiten MIST

Milestone Pharmaceuticals (MIST) is developing an ecosystem of rapid-response solutions for tachycardia treatment via a nasal spray. Patent protection of the method ensures stable sales within emergency medicine. However, preparations for the product's market launch are depleting liquid reserves. The cash per share figure helps identify asset overheating in a timely manner, and 1.17 reflects the latest value of this metric.

Milestone Pharmaceuticals, Inc. (MIST): Dana dhuwit saben saham saka 04.07.2022 nganti 20.11.2026

Rincian metrik komprehensif lan analitis milestonepharma.com (MIST)

- indikator anane dhuwit lan arus kas:
Ringkesan analisis perusahaan:MIST Milestone Pharma
Produk mawa merek Milestone Pharmaceuticals

This metric reflects the volume of liquid assets per common share, allowing for the real-time tracking of actual capital dynamics without the delays of quarterly reporting. By analyzing the cash position per share chart, an investor assesses the resource management efficiency of Milestone Pharmaceuticals (MIST), which is critical given the virtual drug development model and total reliance on external contract manufacturing.